-
2023-510178-15-00
5
2024-07-31
High-risk Large B-cell Lymphoma
-
2022-502781-24-01
5
2024-06-05
ASCVD - Atherosclerotic Cardiovascular Disease
-
2023-506457-38-00
5
2024-06-05
Chronic kidney disease (CKD) and hypertension.
-
2023-505928-59-00
5
2024-04-15
Triple Negative or Hormone Receptor low/HER2-negative Breast Cancer
-
2022-502446-27-00
5
2024-02-26
Relapsed or Refractory Myeloma
-
2023-503428-24-00
4
2024-01-19
Neoplasms, Head and Neck
-
2022-501343-33-00
5
2023-10-18
Biochemically recurrent prostate cancer
-
2022-500430-29-00
5
2023-10-11
Myelodysplastic Syndrome (MDS)
-
2022-502779-40-00
5
2023-09-04
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
-
2022-501419-15-00
5
2023-08-23
Atrial Fibrillation
-
2022-501024-20-00
5
2023-07-25
ER+/HER2- Early Breast Cancer
-
2022-501999-26-00
5
2023-07-12
Severe Hypertriglyceridemia (SHTG)
-
2022-500861-29-00
5
2023-01-12
Relapsed or Refractory Multiple Myeloma (RRMM)
-
2023-505772-30-00
5
2022-11-09
Melanoma
-
2023-505628-67-00
5
2022-10-28
Relapsed and Refractory Follicular Lymphoma
-
2023-508265-33-00
5
2022-10-13
Vasomotor symptoms caused by adjuvant endocrine therapy in women with,
-
2023-504996-26-00
5
2022-07-21
Metastatic Castration Resistant Prostate Cancer (mCRPC)
-
2023-509260-25-00
5
2022-07-12
Locally Recurrent Inoperable or Metastatic Triple-negative Breast Canc
-
2023-507795-51-00
5
2022-05-17
atherosclerotic heart and blood vessel disease (the narrowing of arter
-
2023-508897-27-00
5
2022-04-28
Multiple Myeloma
-
2023-503640-14-00
5
2022-02-17
Newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphobla
-
2024-511599-33-00
5
2021-12-22
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
-
2022-501067-40-00
5
2021-11-30
Moderately to Severely Active Ulcerative Colitis
-
2023-504684-16-00
5
2021-06-05
follicular lymphoma (FL) and marginal zone lymphoma (MZL)